Goldman Sachs
FCSC

Goldman Sachs’s Fibrocell Science Inc. FCSC Stock Holding History

Goldman Sachs’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,762
Closed -$48K – 7089
2017
Q1 		$48K Sell
4,762
-2,542
-35% -$28.2K ﹤0.01% 6303
2016
Q4 		$69K Sell
7,304
-2,131
-23% -$22.9K ﹤0.01% 6302
2016
Q3 		$102K Buy
9,435
+10
+0.1% +$148 ﹤0.01% 6219
2016
Q2 		$163K Buy
9,425
+7,269
+337% +$226K ﹤0.01% 5842
2016
Q1 		$81K Buy
2,156
+797
+59% +$31.8K ﹤0.01% 6187
2015
Q4 		$93K Sell
1,359
-978
-42% -$70.3K ﹤0.01% 6217
2015
Q3 		$135K Sell
2,337
-1,069
-31% -$94.6K ﹤0.01% 6280
2015
Q2 		$269K Sell
3,406
-2,744
-45% -$185K ﹤0.01% 5856
2015
Q1 		$416K Buy
6,150
+1,104
+22% +$71.1K ﹤0.01% 5328
2014
Q4 		$196K Buy
5,046
+46
+0.9% +$1.86K ﹤0.01% 6169
2014
Q3 		$218K Buy
5,000
+862
+21% +$40.4K ﹤0.01% 6084
2014
Q2 		$248K Buy
4,138
+1,353
+49% +$75.5K ﹤0.01% 6027
2014
Q1 		$218K Sell
2,785
-12
-0.4% -$930 ﹤0.01% 6014
2013
Q4 		$170K Sell
2,797
-2,791
-50% -$162K ﹤0.01% 6041
2013
Q3 		$367K Sell
5,588
-1,647
-23% -$133K ﹤0.01% 5414
2013
Q2 		$664K Buy
+7,235
New +$598K ﹤0.01% 4712

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs's FCSC Position: Q2 2017 in Review

Goldman Sachs sold out of Fibrocell Science Inc. (FCSC) in Q2 2017, closing a stake of 4,762 shares — an estimated $48K sold.

Goldman Sachs first reported a position in FCSC in Q2 2013 and held it in 16 quarters. The position peaked at $664K in Q2 2013. 29 funds tracked by Wall St. Rank hold FCSC as of Q2 2017.

  • Goldman Sachs reported no remaining Fibrocell Science Inc. position as of Q2 2017 after selling out during the quarter.
  • Goldman Sachs sold 4,762 Fibrocell Science Inc. shares in Q2 2017, an estimated $48K.
  • Goldman Sachs first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 16 quarters.
  • Goldman Sachs's Fibrocell Science Inc. position peaked at $664K in Q2 2013.
  • 29 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2017.

Based on Goldman Sachs's 13F filing for Q2 2017, filed 14 Aug 2017.